Last week, Mylan N.V. and Biocon Ltd. announced that their jointly-developed insulin glargine biosimilar, Semglee™, received marketing...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
Merck
-
-
On August 8, 2017, Sanofi-Aventis (“Sanofi”) filed a patent infringement suit in the United States District Court for the District of...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
On July 24, 2017, Samsung Bioepis and Merck & Co., Inc. announced the launch of Renflexis® (infliximab-abda) in the United States. ...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Merck & Co., Inc. (“Merck”) announced last week that the FDA has granted tentative approval for its insulin glargine injection...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]